rucaparib
clovis oncology
['rucaparib', 'ovarian', 'gyn', 'brca', 'biomarker']
 practice-changing results from #asco22 in rucaparib (#parpi) as maintenance improves progression free survival in all women w frontline advanced #ovariancancer after response to chemotherapy - regardless of biomarker (#brca, #hrd) status! #gyncsm 
Gyn Onc at MD Anderson. She/Hers. Wife of @DrJasonWestin. Innovative clinical trials. #JCO social media editor. Opinions=mine.
https://t.co/QLXLDKSThc